The role of magnesium orotate in the treatment of arrhythmic syndrome in patients with the connective tissue displasias

The role of magnesium orotate in the treatment of arrhythmic syndrome in patients with the connective tissue displasias

Arrhythmic syndrome associated with connective tissue dysplasia (CTD) is one of the leading lesions of the cardiovascular system in young people. The use of magnesium orotate dihydrate during 4 months allowed to restore the sensitivity of adrenoreceptors, as well as to reduce the incidence of heart...

Full description

Saved in:

Bibliographic Details
Main Authors:	E. N. Loginova, Yu. V. Moskvina, G. I. Nechaeva, I. V. Druk, A. A. Semenkin, M. I. Shupina, Yu. V. Tereschenko
Format:	Article
Language:	Russian
Published:	Open Systems Publication 2021-06-01
Series:	Лечащий Врач
Subjects:	connective tissue dysplasia adrenoreactivity arrhythmia decencitization of adrenoreceptors magnesium orotate dihydrate
Online Access:	https://journal.lvrach.ru/jour/article/view/646
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

ADRENORECEPTOR SENSITIVITY AND MAGNESIUM THERAPY IN PATIENTS WITH CARDIAC ARRHYTHMIAS AND CONNECTIVE TISSUE DYSPLASIA
by: G. I. Nechaeva, et al.
Published: (2012-08-01)

Clinical effectiveness of magnesium orotate in patients with cardiac arrhythmias, arterial hypertension, and mitral valve prolapse
by: E. V. Akatova, et al.
Published: (2009-08-01)

MOLECULAR MECHANISMS OF ACTION OF MAGNESIUM OROTATE ON CARDIOVASCULAR SYSTEM
by: I. Yu. Torshin, et al.
Published: (2016-01-01)

The study of the effects of magnesium orotate on the model of primary generalized convulsions in rats
by: A. G. Kalacheva, et al.
Published: (2017-11-01)

Magnesium Orotate Influence on Thoracic Aorta in Laboratory Rabbits Receiving Levofloxacin
by: N. V. Izmozherova, et al.
Published: (2024-10-01)

CHANGE IN CONTENT OF GLYCOPROTEINS ON THE SURFACE OF ENDOTHELIAL CELL CULTURE EA.HY 926 AND INTIMA OF INTERNAL CAROTID ARTERIES UNDER THE INFLUENCE OF MAGNESIUM OROTATE
by: L. V. Didenko, et al.
Published: (2017-03-01)

FOCUS ON MAGNESIUM BASED DRUGS
by: I. I. Esenova
Published: (2016-01-01)

MAGNESIUM AND MITRAL VALVE PROLAPSE. EFFICACY AND THE POINTS OF APPLICATION
by: A. G. Avtandilov, et al.
Published: (2016-01-01)

Long-term magnesium orotate therapy in patients with mitral valve prolapse
by: A. I. Martynov, et al.
Published: (2012-06-01)

MAGNESIUM DEFICIENCY AND CARDIOVASCULAR DISEASES: TIME TO ACT
by: E. I. Trisvetova
Published: (2015-09-01)

Left-ventricular geometry in young persons with connective tissue dysplasia
by: M. I. Shupina, et al.
Published: (2021-06-01)

MAGNESIUM-CONTAINING DRUGS IN CARDIOVASCULAR DISEASES
by: A. V. Govorin, et al.
Published: (2015-12-01)

Atherogenic hyperadrenoreactivity in men with arterial hypertension
by: S. S. Bunova, et al.
Published: (2009-02-01)

THE EFFECT OF MAGNESIUM DRUGS ON THE PHYSICAL PERFORMANCE OF YOUNG PEOPLE WITH MITRAL VALVE PROLAPSE: RESULTS OF NONCOMPARATIVE STUDY
by: K. M. Dzeranova, et al.
Published: (2015-12-01)

MAGNESIUM IN CLINICAL PRACTICE
by: E. L. Trisvetova
Published: (2015-12-01)

Bisoprolol and sotalol for maintaining sinus rhythm in patients with paroxysmal atrial fibrillation and chronic heart failure
by: S. N. Tereshchenko, et al.
Published: (2005-12-01)

Assessment of subclinical hypertention-mediated heart damage in young adults with connective tissue dysplasia
by: M. I. Shupina, et al.
Published: (2021-09-01)

MORPHOFUNCTIONAL CHARACTERISTICS OF FIBROBLASTS (MCCOY CELL LINE) CULTURED WITH MAGNESIUM PREPARATIONS
by: L. V. Didenko, et al.
Published: (2015-09-01)

Association of polymorphic variants of ADRB1 gene with contractile myocardial dysfunction and erythrocyte adrenoreactivity in patients with rhythm disorders
by: S. A. Afanasiev, et al.
Published: (2019-08-01)

Role of genetic research in the prevention of life-threatening rhythm and cardiac conduction disorders in young people
by: E. N Loginova, et al.
Published: (2022-11-01)

Sympathetic activity and arterial hypertension: potential for correction
by: O. Yu. Shayduk, et al.
Published: (2013-04-01)

COMPARATIVE EFFECTS OF MONOTHERAPY WITH MAGNESIUM AND COMBINED THERAPY WITH MAGNESIUM AND Β-BLOCKER ON PRIMARY MITRAL VALVE PROLAPSE WITH HEART RHYTHM DISORDERS
by: E. G. Nurtdinova, et al.
Published: (2015-12-01)

Effect of magnesium on the cardiovascular system in women
by: E. A. Ulubieva, et al.
Published: (2016-03-01)

Genetic polymorphisms associated with the development of arrhythmic type of cardiovascular events
by: G. R. Gimatdinova, et al.
Published: (2022-09-01)

PATHOLOGY OF THORACIC AORTA IN CONNECTIVE TISSUE DYSPLASIAS
by: G. I. Nechaeva, et al.
Published: (2018-03-01)

Combined uterorelaxant effect of magnesium sulfate and terbutaline: Studies on late pregnant rat uteri in vitro and in vivo
by: Tamara Barna, et al.
Published: (2023-04-01)

ARRHYTHMIC PHENOTYPE OF NON-COMPACTION CARDIOMYOPATHY
by: S. M. Komissarova, et al.
Published: (2021-05-01)

Carvedilol and its combination with digoxin for heart rate control in patients with persistent atrial fibrillation and chronic heart failure
by: S. N. Tereshchenko, et al.
Published: (1970-01-01)

THE GENE OF ALPHA2A-ADRENORECEPTOR AND ESSENTIAL ARTERIAL HYPERTENSION
by: T. A. Bairova, et al.
Published: (2014-11-01)

Thermodynamic Behavior of Erythromycin Thiocyanate Dihydrate in Six Pure Solvents and Two Binary Solvents
by: Jin Feng, et al.
Published: (2025-05-01)

CLINICAL AND GENETIC PECULIARITIES OF ATRIAL FIBRILLATION
by: S. Y. Nikulina, et al.
Published: (2016-01-01)

Сardioprotective agents with biaromatic structure. Part 6. Beta blockers
by: G. V. Mokrov
Published: (2023-11-01)

EFFECT OF MAGNESIUM OROTATE ON CONNECTIVE TISSUE MATRIX AND CARDIAC INOTROPIC FUNCTION IN PATIENTS WITH MITRAL VALVE PROLAPSE. CLINICAL AND MORPHOLOGICAL STUDY
by: A. G. Avtandilov, et al.
Published: (2015-09-01)

Status and function of betaDadrenoreceptors and their modification during betaDblocker treatment in patients with arterial hypertension and chronic heart failure
by: O. A. Maneshina, et al.
Published: (2005-10-01)

Diastolic cardiac function in connective tissue dysplasia
by: Yu. V. Tereschenko, et al.
Published: (2021-06-01)

Prognostic relevance of arrhythmic and QTc burden in takotsubo cardiomyopathy: A systematic review and meta‐analysis
by: Ankit Hanmandlu, et al.
Published: (2025-08-01)

Binders for pressed products based on phosphogypsum waste
by: Leonid Dvorkin, et al.
Published: (2022-12-01)

FEATURES OF IMMUNE RESPONSE IN PRETERM BABIES WITH BRONCHOPULMONARY DISPLASIA OF VARIOUS SEVERITY
by: G. N. Chistyakova, et al.
Published: (2019-07-01)

Dynamics of magnesemia levels, structural-functional heart parameters and arrhythmia syndrome features in patients with myocardial infarction and undifferentiated connective tissue dysplasia against the background of drug correction with magnesium
by: E. P. Miroshnichenko, et al.
Published: (2018-12-01)

Biological activity produced by ruthenium chloride on perfusion pressure, left ventricular pressure and heart failure using an isolated rat heart model
by: Figueroa-Valverde Lauro, et al.
Published: (2024-07-01)